Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Fourteen Day Treatment With Lansoprazole 15 mg or 30 mg Once a Day in Frequent Nighttime Heartburn

Next Previous
X
Search
Trial Profile

A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Fourteen Day Treatment With Lansoprazole 15 mg or 30 mg Once a Day in Frequent Nighttime Heartburn

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 28 Jan 2010

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lansoprazole (Primary)
  • Indications Heartburn
  • Focus Therapeutic Use
  • Sponsors Novartis

    • Most Recent Events

    • 01 Sep 2009 Results have been reported in Alimentary Pharmacology and Therapeutics.
    • 04 Jun 2009 The primary endpoint 'Night-time-symptom-free-days' has been Met according to the poster presented at Digestive Disease Week 2009, 30 May 2009.
    • 04 Jun 2009 Results published as an abstract in the proceedings of Digestive Disease Week 2009.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top